Efficacy and safety outcomes of PD-1/PD-L1 inhibitors in recurrent cholangiocarcinoma: a real-world, multicenter and retrospective study.

ABSTRACT:

SUBMITTER: Lin L 

PROVIDER: S-EPMC12211396 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature